Newsroom

The first edition of the Innovations in Hearing Implants (IHI 2026) conference brought together 121 participants from academia, clinical practice, research institutes, and industry from around the world.

The Innovations in Hearing Implant Research Conference (IHI 2026) will bring together hearing specialists from 30 September to 3 October to discuss the latest advances in hearing implants, from basic research to clinical applications.

Research led by the Institut and the Institut de Recerca Sant Pau (IR Sant Pau) shows in an animal model that two compounds capable of activating antioxidant defence mechanisms can reduce pain hypersensitivity and depressive-like behaviours associated with fibromyalgia. Read the article

A large share of scientific research is funded with public money, yet only a small proportion is ever communicated to society. A new study by the communications department of the Institute and the University of Vic – Central University of Catalonia (UVic-UCC) shows that research centres and universities need to actively promote their findings if they want them to reach the news media.

Dr. Adam Ranson, group leader at the Institute, has been awarded an ERC Proof of Concept Grant for NEURODOCK, a project that aims to develop a new technology for studying brain activity in mice under more natural conditions.

From 9 to 11 June, the Institute hosted the second edition of the "Basic Training on Miniscopes in Neuroscience" course, an initiative led by AnderoLab to bring cutting-edge neural imaging techniques closer to students and researchers.

A study led by Dr. Raül Andero suggests that assessing the relationship between two hormones present in both men and women, estradiol and progesterone, could help better understand how memory works. Read the article

The 13th edition of the Cajal Conference 2026, organized by the Sociedad Española de Neurociencia, was held last week in Cádiz. The meeting, which included members of the Institute on the organizing committee, served to share advances, foster scientific debate, and promote new collaborations within the neuroscience community.

A study by the University of Canterbury, in collaboration with the Institute, reveals how a disabled kea without an upper beak became the dominant male in his group through a unique fighting strategy.

The European Medicines Agency (EMA) has designated as an orphan drug a compound based on the bioactive lipid molecule Maresin-1 (MaR1), currently being investigated by a research team from the UAB for the treatment of spinal cord injuries.